Introduction
Retinoblastoma (RB) is a prototype of inheritable cancers. It is the most common primary intraocular tumor in the pediatric age group. [1] It has been found to affect the lower socioeconomic strata more frequently, which also appears to have an implication on the stage at presentation of the disease. According to various studies, RB could metastasize within 6 months of onset of symptoms, if left untreated. [2] Therefore, delay in diagnosis may result in poorer outcome. We have analyzed the clinicopathological profile of children diagnosed with RB in our institute, primarily to understand the epidemiology and also to study the relationship between advanced disease and delayed presentation. The early detection would improve patient outcomes significantly and in familial cases may help detection in the contralateral eye earlier, aiding vision salvage. We thereby wish to propose a screening strategy for all children, during routine pediatrician visits.
Methodology
All the patients who were registered in the Pediatric Oncology Department, Kidwai Cancer Institute with the diagnosis of RB, between the years 2009 and 2014, were included in the study retrospectively. Diagnosis of RB was confirmed clinically and by imaging. Computed tomography (CT) scan or magnetic resonance imaging (MRI) was performed based on availability. A routine bone marrow examination and cerebrospinal fluid (CSF) analysis were performed in all these children. Chest X-ray and bone scan were also done as a part of metastatic workup.
Results
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Pediatric and Adolescent Cancers ORIGINAL ARTICLE and chest X-ray were done as a part of metastatic workup. Bone marrow involvement was detected in 3/53 (5%) and lung metastasis in 1/53 (2%). Intracranial involvement was found in 5/53 (10.4%), and CSF showed malignant cells in 8/53 (15%). Eighteen patients were referred postsurgery, and 11 were started on neoadjuvant chemotherapy at another center followed by enucleation. Most of the children presented with advanced disease. We identified that those children with high-risk features (28/53) had a significant delay in presentation in comparison to those without high-risk features, as represented in Table 1 (P = 0.035). Out of the patients that took treatment in our institute, only 39.6% completed the scheduled therapy. Therefore, outcome analysis could not be performed. Twenty-four patients refused treatment following diagnosis and prognostication based on severity of disease. Twenty-nine patients agreed for chemotherapy, of which 8 had irregular follow-up and did not complete therapy.
Discussion
RB is a prototype of heritable cancers and is the most common intraocular tumor in the pediatric age group. Most of these tumors are sporadic and unilateral in up to 60% of the cases. The remaining 40% are inherited, with bilateral presentation seen in 25% of the cases. [3] The median age at diagnosis is 18 months, an average of 12 months for children with bilateral disease and 24 months for children with unilateral disease. [4] Approximately 95% of children with RB present before the age of five. [4] Our group had a male predominance with a male: female ratio of 1.2:1. Bilateral disease was found in 39%. Although it is well known that bilateral tumors tend to present early, in our group, there was a difference. [5] The mean age of children with bilateral RB was 25 months, against 18 months in unilateral cases. The median duration of illness was 3 months (range 1-5 months). The two-hit hypothesis comes to play in RB with an autosomal-dominant inheritance pattern. [1] While it is ideal to detect RB early, it is unfortunate that a significant proportion of patients present with advanced disease. As RB is commonly seen in the lower socioeconomic strata in our country, lack of awareness is one of the main reasons why parents do not seek medical assistance early. Unsatisfactory visual prognostication and therapy-related complications lead to refusal of treatment. In our group of patients, only 54.7% agreed for treatment and only 39.6% completed the scheduled therapy. The most common presenting features was leukocoria, followed by mass protruding from the eye and strabismus. Vision loss was observed in 46.2%. This is in concurrence with the other major study from AIIMS, India. [6] The tumor was intraocular in 41.6% and extraocular in 58.4% cases. Most common site of metastasis in our group was to the central nervous system. This is in contrast to most studies that indicate bone to be the most common site of metastasis in RB. However, central nervous system was the most common site of metastasis in the above mentioned study from India, which is in concurrence with our data as well. [6] The average age of children with metastasis was 32 months. This was much higher than the average age in unilateral cases, indicating delayed presentation probably resulted in metastatic disease in these children. Any child presenting with new-onset strabismus should be evaluated for possibility of an underlying RB. [7] Several viruses have also been implicated in the etiopathogenesis such as human papillomavirus, simian virus, and adenovirus. A study from our own institute had shown positive correlation between HPV infection in the mother and development of RB in the child. [8] Several prognostic factors have been defined in RB. Choroidal invasion, optic nerve involvement, orbital extension, and intracranial extension are well-known risk factors. Choroidal invasion alone has not shown any significant decrease in outcome, but when combined with the rest, it significantly lowers the survival in patients with RB. [9] In our children, 54.7% had presented with the above risk features. This is slightly higher than some case series that quote an incidence of high-risk features in RB to be 40%-50%. [10] In 15% of the children, more than one risk feature were observed. These high-risk features are a concern mainly because they are associated with high incidence of extraocular relapse and low chances of recovering vision. Multimodality treatment with chemotherapy, surgery, and radiotherapy are needed for adequate disease control. Chemotherapy if administered alone has inadequate central nervous system penetration and therefore can result in extraocular relapse. [10] We would like to emphasize that children with a white reflex must be screened at the earliest for underlying RB. Considering that it is the most common symptom and is likely to be picked up even in a photograph, it is important to sensitize the general pediatricians to routinely screen the children during vaccination visits. Early detection can aid better survival and improve visual prognosis in these children. Twelve out of the 53 children's parents had noticed a white reflex in photographs several months before presentation. However, due to lack of awareness, this was not given medical attention despite the fact that these children had regular vaccination visits to their local health facility.
Conclusion
RB is curable in 90% cases in the developed countries, while the cure rate continues to be far lesser in developing countries. The prevalence of metastatic disease with delayed presentation is still high in lower middle-income countries like ours, which remains the main culprit for poorer outcome in RB. [11] With mobile phone cameras being widely accessible, creating awareness about the white reflex and routine basic eye examination during the vaccination visits are essential for identifying disease at an early stage. Aggressive multimodality treatment can aid adequate disease control and vision salvage. 
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Letter to the Editor
Isolated regional nodal metastasis in giant cell tumor of the bone: Case report and review of literature
Dear Editor, Giant cell tumors (GCTs) of the bone are benign osteolytic tumor commonly occurring in the third to fourth decades with distal femur being the most common site. [1] They form 5% of the primary skeletal tumors. [2] Metastasis though uncommon is usually seen with recurrences. Curettage with intralesional adjuvant therapy with polymethylmethacrylate, liquid nitrogen, and bone graft has been successfully used to reduce recurrences while preserving function. [3] The management of metastasis is still debatable due to the scarcity of literature.
A 47-year-old female who was diagnosed to have GCT of the left radius for which she underwent left distal radius curettage with bone grafting. After 1 year of disease-free interval (DFI), she developed local recurrence and underwent en bloc resection of radius with reconstruction using nonvascularized fibula graft with plating. She developed local recurrence in the soft tissue in the next 2 years which was managed by wide local excisions. After a DFI of 1 year, she presented with an enlarged mobile epitrochlear node, fine-needle aspiration cytology of which was suggestive of GCT. Computed tomography of the chest showed no pulmonary metastasis. The patient was discussed in multispecialty board and she underwent epitrochlear nodal dissection. The final histopathology showed five nodes, with one node showing metastatic GCT. There was no perinodal spread. Figures 1 and 2 show the presence of tumor within the lymph nodes. She is on regular follow-up for 1 year and has shown no sign of recurrence.
GCT is characterized by scattered multinucleate giant cells among mononuclear stromal cells, together imparting a syncytium-like appearance causing a typical radiolucent lytic shadow on X-ray. [4] The tumor is known for its propensity for local recurrences which are generally amenable to wide excisions. The potential for metastatic spread was first reported by Jaffe et al. in 1940. [5] Distant metastasis is seen in 2%-3% of cases with the lungs being the most common site of distant metastasis and the incidence of pulmonary metastasis varies from 4% to 11% in the literature. [6] Other uncommon sites being the bone, skin, soft tissue, breast, and endobronchial tree have also been reported. [7] Lymph nodal involvement is very rare in GCT and only 13 cases have been reported in the English literature. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Table 1 lists the cases of GCT with lymph node involvement. Dyke, in 1931, reported the presence of GCT in lymph nodes in a case with extensive metastatic disease. [8] Since then, majority have reported mediastinal and para-aortic nodal involvement. Only five have reported regional lymph node involvement, of which two were associated with pulmonary metastasis. [7, [9] [10] [11] [12] Isolated regional node involvement as seen in our case has been reported previously only in three cases. [9] [10] [11] Budzilovich et al. reported the first regional nodal involvement in 1963. [9] Present et al., in 1986, reported a GCT metastasizing to regional lymph node; however, it spread to lungs after a year. [10] In another case reported by Aftab and Umar, there was axillary nodal spread from GCT of the distal humerus without pulmonary involvement. [11] In one of the largest reviews from a tertiary care center, Viswanathan and Jambhekar retrospectively evaluated 470 patients of GCTs, of which 24 had distant metastasis and only one patient had regional lymph node metastasis to inguinal lymph node. In their patient, the primary site was femur and there were multiple lung metastasis along with lymph node metastasis. The authors concluded that there was no association between clinicopathological variables and the development of metastasis. [12] The mechanism of pulmonary metastasis has been speculated to be tumor emboli either upfront or during the time of curettage. Lymphatic spread can also be explained similarly by the multiple surgeries performed previously for our patient.
Metastatic GCT has been successfully treated with complete resection of primary and the metastasis. Pulmonary metastatectomy has been routinely performed in resectable patients, with similar principle applied for lymph node metastasis also. All four cases with regional lymph node metastasis have been managed with surgical resection. Connell et al. successfully managed a patient with excision of primary patellar GCT along with excision of posterior mediastinal
